Peroxiredoxin 1 (PRDX1), an enzyme involved in oxidative stress, has the ability to identify cerebral infarction with a specificity of 86% and sensitivity of 53%, and could be a new biomarker in TIA diagnosis [55]. This evidence concerns the gene PRDX1 and cerebral infarction.